Clinical Trials Directory

Trials / Completed

CompletedNCT05550688

Weight Gain After Smoking Cessation and NAFLD

The Effect of Weight Gain After Smoking Cessation Increased the Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease

Status
Completed
Phase
Study type
Observational
Enrollment
12,941 (actual)
Sponsor
Ningbo No. 1 Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common chronic liver disease. Considering that there are no approved pharmacological treatments, lifestyle modification is necessary and challenging to reduce the risk of type 2 diabetes mellitus (T2DM) in patients with NAFLD. Cigarette smoking has a significant negative impact on public health, causing more than 480,000 deaths each year. Smoking has been reported as a risk factor for NAFLD and might accelerate liver disease progression. Therefore, it is recommended that patients with NAFLD quit smoking. However, smoking cessation could be complicated by weight gain. Thus, it is important to assess the impact of weight change after smoking cessation on patients with NAFLD. Proper management of post-cessation weight could maximize its health benefits. In this large-scale cohort study, the investigators aimed to assess the effects of smoking cessation and subsequent weight change on risks of incident T2DM in individuals with NAFLD.

Conditions

Timeline

Start date
2007-01-01
Primary completion
2014-12-31
Completion
2022-08-01
First posted
2022-09-22
Last updated
2022-09-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05550688. Inclusion in this directory is not an endorsement.